XML 70 R61.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense $ 10.4 $ 8.9 $ 20.5 $ 17.9
Cost of molecular diagnostic testing        
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense 0.5 0.4 0.8 0.7
Cost of pharmaceutical and clinical services        
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense 0.0 0.0 0.0 0.1
Research and development expense        
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense 1.0 1.0 3.4 2.5
Selling, general, and administrative expense        
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense $ 8.9 $ 7.5 $ 16.3 $ 14.6